[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

FI813089L - Beta-laktamantibiotica foerfarande foer deras framstaellning samt dessa innehaollande aemnen - Google Patents

Beta-laktamantibiotica foerfarande foer deras framstaellning samt dessa innehaollande aemnen

Info

Publication number
FI813089L
FI813089L FI810389A FI813089A FI813089L FI 813089 L FI813089 L FI 813089L FI 810389 A FI810389 A FI 810389A FI 813089 A FI813089 A FI 813089A FI 813089 L FI813089 L FI 813089L
Authority
FI
Finland
Prior art keywords
beta
laktamantibiotica
aemnen
foerfarande foer
deras framstaellning
Prior art date
Application number
FI810389A
Other languages
English (en)
Other versions
FI75825B (fi
FI75825C (fi
Inventor
Michael Boberg
Karl Georg Metzger
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of FI813089L publication Critical patent/FI813089L/fi
Publication of FI75825B publication Critical patent/FI75825B/fi
Application granted granted Critical
Publication of FI75825C publication Critical patent/FI75825C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D261/00Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/08Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/54Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D499/00Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Fodder In General (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
FI813089A 1980-10-08 1981-10-06 Foerfarande foer framstaellning av -laktamantibiotika. FI75825C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19803037997 DE3037997A1 (de) 1980-10-08 1980-10-08 (beta) -lactamantibiotika, verfahren zu deren herstellung sowie sie enthaltende mittel
DE3037997 1980-10-08

Publications (3)

Publication Number Publication Date
FI813089L true FI813089L (fi) 1982-04-09
FI75825B FI75825B (fi) 1988-04-29
FI75825C FI75825C (fi) 1988-08-08

Family

ID=6113915

Family Applications (1)

Application Number Title Priority Date Filing Date
FI813089A FI75825C (fi) 1980-10-08 1981-10-06 Foerfarande foer framstaellning av -laktamantibiotika.

Country Status (15)

Country Link
US (1) US4416880A (fi)
EP (1) EP0049448B1 (fi)
JP (4) JPS5793982A (fi)
AT (1) ATE36714T1 (fi)
AU (1) AU554294B2 (fi)
CA (1) CA1178946A (fi)
DE (2) DE3037997A1 (fi)
DK (1) DK165924C (fi)
ES (1) ES506115A0 (fi)
FI (1) FI75825C (fi)
GR (1) GR75073B (fi)
HK (1) HK6191A (fi)
HU (1) HU186429B (fi)
IL (1) IL63959A (fi)
ZA (1) ZA816932B (fi)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3145727A1 (de) * 1981-11-19 1983-05-26 Bayer Ag, 5090 Leverkusen Zwischenprodukte, verfahren zu deren herstellung und verfahren zur herstellung von cephalosporinen
CA1201431A (en) * 1981-12-17 1986-03-04 Daiei Tunemoto .beta.-LACTAM COMPOUNDS, PROCESS FOR THE PREPARATION THEREOF AND INTERMEDIATE PRODUCTS FOR THE PREPARATION THEREOF
DE3224866A1 (de) * 1982-07-02 1984-01-05 Bayer Ag, 5090 Leverkusen Ss-lactamantibiotika, verfahren zu deren herstellung sowie sie enthaltende mittel
DE3239365A1 (de) * 1982-10-23 1984-04-26 Bayer Ag, 5090 Leverkusen Neue cephalosporine und verfahren zu ihrer herstellung
DE3300593A1 (de) * 1983-01-11 1984-07-12 Bayer Ag, 5090 Leverkusen Neue cephalosporine und verfahren zu ihrer herstellung
JPS6034957A (ja) * 1983-08-05 1985-02-22 Meiji Seika Kaisha Ltd 2−置換メチレン−2−(2−アミノチアゾ−ル−4−イル)酢酸誘導体及びその製造方法
DE3329427A1 (de) * 1983-08-13 1985-02-21 Bayer Ag, 5090 Leverkusen 7-amino-3(1-pyridiniomethyl)-8-oxo-5-oxa-1-azabicyclo(4.2.0)oct-2-en-2-carboxylate, verfahren zu ihrer herstellung und ihre verwendung als zwischenprodukte zur synthese von ss-lactam-antibiotika
AU575854B2 (en) * 1983-10-04 1988-08-11 Shionogi & Co., Ltd. 7beta-(carboxyalkenamido) cephalosporins
DE3343208A1 (de) * 1983-11-30 1985-06-05 Bayer Ag, 5090 Leverkusen Neue cephalosporine und verfahren zu ihrer herstellung
DE3418376A1 (de) * 1984-05-17 1985-11-21 Bayer Ag, 5090 Leverkusen Zwischenprodukte sowie verfahren zur herstellung von zwischenprodukten fuer die synthese von cephalosporinen
DE3419012A1 (de) * 1984-05-22 1985-11-28 Bayer Ag, 5090 Leverkusen Ss-lactamantibiotika, verfahren zu deren herstellung sowie ihre verwendung als arzneimittel oder wachstumsfoerderer in der tieraufzucht oder als antioxidantien
JP2501785B2 (ja) * 1984-07-09 1996-05-29 明治製菓株式会社 新規セフアロスポリン系化合物
JPS6153272A (ja) * 1984-08-24 1986-03-17 Shionogi & Co Ltd グルタル酸誘導体の製法
JPS61205282A (ja) * 1985-03-08 1986-09-11 Sagami Chem Res Center β−ラクタム化合物類
AT397963B (de) * 1985-03-29 1994-08-25 Shionogi & Co Verfahren zur herstellung von neuen 7 beta-(2-(2- amino-4-thiazolyl)-alkenoylamimo)-3-cephem-4- carbonsäureestern
AU580855B2 (en) * 1985-03-29 1989-02-02 Shionogi & Co., Ltd. Alkeneamidocephalosporin esters
US4731362A (en) * 1985-08-05 1988-03-15 Shionogi & Co., Ltd. Alkylcarbamoyloxymethylcephem compounds
DE3541095A1 (de) * 1985-11-21 1987-05-27 Bayer Ag Neue cephalosporine, verfahren zu deren herstellung sowie ihre verwendung als arzneimittel
US5017380A (en) * 1986-07-02 1991-05-21 Shionogi & Co., Ltd. Gelatin hard capsule containing crystalline hydrate of oral cephalosporin
NZ220764A (en) * 1986-07-02 1989-09-27 Shionogi & Co Crystalline form of 7beta((z)-2-(2-aminothiazol-4-yl)-4- carboxybut-2-enoylamino)-3-cephem-4-carboxylic acid and pharmaceutical compositions
US5079242A (en) * 1987-03-11 1992-01-07 Pfizer Inc. Substituted 3-cephem compounds as antibacterial agents
IL89836A0 (en) * 1988-04-06 1989-12-15 Beecham Group Plc Penicilanic acid derivatives,process for their preparation and pharmaceutical compositions containing them
GB8906592D0 (en) * 1989-03-22 1989-05-04 Beecham Group Plc Novel compounds
MA21969A1 (fr) * 1989-10-05 1991-07-01 Beecham Group Plc Procede de preparation de nouveaux composes contenant un cycle beta - lactame .
GB8922410D0 (en) * 1989-10-05 1989-11-22 Beecham Group Plc Novel compounds
GB9117783D0 (en) * 1991-08-17 1991-10-09 Smithkline Beecham Plc Novel compounds
JP3217191B2 (ja) * 1992-07-16 2001-10-09 ビーエーエスエフ アクチェンゲゼルシャフト ヘテロ芳香族化合物およびこれを含有する植物保護剤
CA2287663C (en) * 1998-11-02 2008-04-08 Isao Kurimoto Process for producing 2-alkylidene-4-bromoacetoacetic acid ester
DE69911348T2 (de) 1998-11-12 2004-07-15 Shionogi & Co., Ltd. Herstellung von Derivaten von 2-Aminothiazol Hydrobromid Z-Isomeren
CN102827188B (zh) * 2012-08-25 2014-09-10 河北农业大学 一种青霉素类药物通用半抗原、人工抗原、广谱单克隆抗体及其制备方法与应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS435888B1 (fi) * 1964-03-14 1968-03-04
US3622569A (en) * 1969-08-05 1971-11-23 R & L Molecular Research Ltd 6-(2-aryl-3-azido-and-3-amino-methyl-isocrotonamido)penicillanic acids
GB1497039A (en) * 1973-12-05 1978-01-05 Glaxo Lab Ltd Penicillins and cephalosporins
US4182868A (en) * 1974-10-29 1980-01-08 Takeda Chemical Industries, Ltd. 7-Methoxycephalosporin derivatives
US4298606A (en) * 1974-12-19 1981-11-03 Takeda Chemical Industries, Ltd. Thiazolylacetamido compounds
FR2340093A1 (fr) * 1976-02-05 1977-09-02 Roussel Uclaf Derives de l'acide 3-carbamoyloxymethyl 7-amino thiazolyl acetamido cephalosporanique, leur procede de preparation et leur application comme medicaments
DE2758000A1 (de) * 1977-12-24 1979-07-05 Hoechst Ag Verfahren zur herstellung von penicillinen und cephalosporinen
FR2387235A1 (fr) * 1978-01-23 1978-11-10 Fujisawa Pharmaceutical Co Procede de preparation de composes d'acide 3,7-disubstitue-3-cephem-4-carboxylique et nouveaux produits ainsi obtenus, ayant une forte activite antibacterienne
US4310459A (en) * 1978-04-03 1982-01-12 Bristol-Myers Company Process for producing carbamoyl substituted penams and carbamoyl substituted cephams from penicillin sulfoxide esters
DE2818263A1 (de) * 1978-04-26 1979-11-08 Bayer Ag Beta-lactamantibiotika
US4275062A (en) * 1979-09-19 1981-06-23 E. R. Squibb & Sons, Inc. Aminothiazolyl ureido sulfoxide cephalosporins
GB2076801A (en) * 1980-04-14 1981-12-09 Erba Farmitalia alpha , beta -Disubstituted Acrylamido Cephalosporins
CA1178947A (en) * 1980-09-26 1984-12-04 Sagami Chemical Research Center .beta.-LACTAM COMPOUNDS AND PROCESS FOR THEIR PREPARATION

Also Published As

Publication number Publication date
FI75825B (fi) 1988-04-29
GR75073B (fi) 1984-07-13
AU554294B2 (en) 1986-08-14
DE3176851D1 (en) 1988-09-29
ES8206532A1 (es) 1982-08-16
DK165924B (da) 1993-02-08
HK6191A (en) 1991-01-25
EP0049448B1 (de) 1988-08-24
DK444581A (da) 1982-04-09
DE3037997A1 (de) 1982-05-13
JPS61106579A (ja) 1986-05-24
DK165924C (da) 1993-06-28
EP0049448A2 (de) 1982-04-14
JPS5793982A (en) 1982-06-11
JPH0662631B2 (ja) 1994-08-17
ATE36714T1 (de) 1988-09-15
JPS6337107B2 (fi) 1988-07-22
US4416880A (en) 1983-11-22
CA1178946A (en) 1984-12-04
JPS6193173A (ja) 1986-05-12
ZA816932B (en) 1982-09-29
JPH02209877A (ja) 1990-08-21
ES506115A0 (es) 1982-08-16
FI75825C (fi) 1988-08-08
EP0049448A3 (en) 1983-05-11
HU186429B (en) 1985-07-29
AU7613381A (en) 1982-04-22
IL63959A (en) 1985-07-31
IL63959A0 (en) 1981-12-31

Similar Documents

Publication Publication Date Title
FI813089L (fi) Beta-laktamantibiotica foerfarande foer deras framstaellning samt dessa innehaollande aemnen
ES2032229T3 (es) Inhibidores de proteasas benzamidicos.
NO164351C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-alkyl-l-fenyl-2-piperazinoalkylpyrazolin-3-on-forbindelser.
SE7613304L (sv) Forfarande for framstellning av 7-metoxicefalosporiner
ES2002420A6 (es) Procedimiento para la preparacion de derivados del oxazol e isoxazol
DE3661071D1 (en) 4,5-substituted-1,3-thiazol-2-yloxyacetamide
ES2019667B3 (es) Derivados de azolsemiaminal y su aplicacion como inhibidores de nitrificacion.
ATE127451T1 (de) 3,4-disubstituierte phenyl-heterocyclen und deren verwendung.
GR77419B (fi)
ES523797A0 (es) Procedimiento para la obtencion de b-lactamantibioticos.
JPS57130987A (en) Ketohydroxyiminocephalosporins
FI810618L (fi) Nya kefalosporiner foerfarande foer deras framstaellning och dessa foereningar innehaollande laekemedel
SE8000298L (sv) Karbamatderivat av merkaptoacylhydroxiproliner
SE8704551D0 (sv) New benzo(g)quinolines
SE7704033L (sv) Oxotiaforeningar
GB2015527A (en) Phosphinic Acid Derivatives of N-Aminothio-N-Methylcarbamates
KR830002783A (ko) 3-비닐-세팔로스포린 유도체 제조방법
ES482962A1 (es) Procedimiento para la preparacion de compuestos de cefem

Legal Events

Date Code Title Description
MA Patent expired

Owner name: BAYER AKTIENGESELLSCHAFT